Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00307333 · ClinicalTrials.gov registry record · NA
Impact of Heart Rate Characteristics Monitoring in Neonates
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 3,003
- Enrollment target
NCT00307333: Completed NA study, sponsored by University of Virginia.
NCT00307333 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 3,003 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00307333, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,003 participants
- Enrollment target
Study Summary
Hypothesis: Fewer neonates managed using information from heart rate characteristics (HRC) will require intubation and mechanical ventilation as a result of sepsis and sepsis-like illness. Infants will be randomly assigned to one of two groups. One group of infants will have the HRC index known to the physicians caring for them, and physicians will use the HRC index as they desire to aid in clinical management. Infants in the other group will have the HRC index recorded, but this information will not be displayed to the physicians caring for the infants.
Interventions
- DEVICE HeRO heart rate characteristics monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,003 participants |
| Start Date | 2005-08 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT00307333 record still lists
NCT00307333 is an interventional study that assigns participants to a tested intervention. Its 3,003 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (114% higher).
The record links to 0 conditions, and to 1 intervention - of which HeRO heart rate characteristics monitor is the first listed.
NCT00307333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00307333 about?
NCT00307333 is a clinical study titled "Impact of Heart Rate Characteristics Monitoring in Neonates". Hypothesis: Fewer neonates managed using information from heart rate characteristics (HRC) will require intubation and mechanical ventilation as a result of sepsis and sepsis-like illness. Infants will be randomly assigned to one of two groups. One group of infants will have the HRC index known to ...
What is the current status of trial NCT00307333?
This trial is currently completed. It is a NA study. The enrollment target is 3,003 participants. The study started on 2005-08. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00307333?
The interventions under investigation include: HeRO heart rate characteristics monitor (DEVICE).
Who is sponsoring clinical trial NCT00307333?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00307333's enrollment target sits among peer trials
3,003 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia